Search for: "Anda Pharmaceuticals, Inc" Results 101 - 120 of 605
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Feb 2017, 9:13 pm by Patent Docs
The lawsuit involved Watson's ANDA filing seeking approval for a generic version of Shire's controlled-release oral pharmaceutical composition for the treatment of inflammatory bowel disease, Crohn's disease, and ulcerative colitis, sold by Shire under the brand name LIALDA®. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al. [read post]
30 Nov 2016, 10:22 am by Overhauser Law Offices, LLC
Defendant Akorn, Inc., a generic drugmaker based in Lake Forest, Illinois, filed an Abbreviated New Drug Application (“ANDA”) with the U.S. [read post]
19 Nov 2016, 4:48 am by Gregory B. Williams
Teva Pharmaceuticals USA, Inc., Civil Action No. 14-874-SLR (D.Del., November 16, 2016), the Court found the asserted claims of U.S. [read post]
31 Oct 2016, 11:33 am
The parties in this litigation are engaged in the development and sale of pharmaceuticals. [read post]
8 Oct 2016, 3:25 am by Gregory B. Williams
Plaintiffs, Endo Pharmaceuticals Inc. and Mallinckrodt LLC, filed these patent infringement actions against defendants Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals of New York, LLC (collectively, “Amneal”), Teva Pharmaceuticals USA, Inc. and Barr Laboratories, Inc. [read post]
4 Sep 2016, 9:13 pm by Patent Docs
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
26 Jul 2016, 8:45 pm by Patent Docs
LLC Defendant: Zydus Pharmaceuticals (USA) Inc. [read post]
14 Jul 2016, 2:37 pm by Eric Caligiuri
Hospira Inc., Federal Circuit case number 2014-1469, that to be “on sale” under pre-AIA 35 U.S.C. [read post]